Main Article Content
Therapeutic consultation by patients is made complete by drug management which is expected to solve the patients’ problems. Pharmaceutical product cross-contamination is a serious problem which has been detected as an obstacle towards successful therapeutic goals. In the pharmaceutical care of patients in developed countries, cross-contamination of drugs has been well addressed and controlled unlike in most developing countries including Tanzania. This review intends to provide insight into this problem, aiming at increasing awareness on the health impacts of crosscontamination on patients in order to promote preventive strategies employed in combating cross-contamination in both industrial and clinical pharmacy practice.